317 related articles for article (PubMed ID: 34512152)
21. The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer.
Sidorova EA; Zhernov YV; Antsupova MA; Khadzhieva KR; Izmailova AA; Kraskevich DA; Belova EV; Simanovsky AA; Shcherbakov DV; Zabroda NN; Mitrokhin OV
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768298
[TBL] [Abstract][Full Text] [Related]
22. Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.
Yao D; Jiang Y; Gao S; Shang L; Zhao Y; Huang J; Wang J; Yang S; Chen L
Cell Prolif; 2016 Oct; 49(5):541-53. PubMed ID: 27436709
[TBL] [Abstract][Full Text] [Related]
23. Diet, microRNAs and prostate cancer.
Saini S; Majid S; Dahiya R
Pharm Res; 2010 Jun; 27(6):1014-26. PubMed ID: 20221895
[TBL] [Abstract][Full Text] [Related]
24. Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies.
Syed RU; Alshammari MD; Banu H; Khojali WMA; Jafar M; Nagaraju P; Alshammari A
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38761210
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs and cancer: current state and future perspectives in urologic oncology.
Schaefer A; Jung M; Kristiansen G; Lein M; Schrader M; Miller K; Stephan C; Jung K
Urol Oncol; 2010; 28(1):4-13. PubMed ID: 19117772
[TBL] [Abstract][Full Text] [Related]
26. An Updated Review of the Pre-Clinical Role of microRNAs and their Contribution to Colorectal Cancer.
Dastmalchi N; Safaralizadeh R; Teimourian S
Curr Mol Med; 2022; 22(10):851-859. PubMed ID: 34961460
[TBL] [Abstract][Full Text] [Related]
27. The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target.
Sameti P; Tohidast M; Amini M; Bahojb Mahdavi SZ; Najafi S; Mokhtarzadeh A
Cancer Cell Int; 2023 Jul; 23(1):134. PubMed ID: 37438760
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-modulated autophagic signaling networks in cancer.
Fu LL; Wen X; Bao JK; Liu B
Int J Biochem Cell Biol; 2012 May; 44(5):733-6. PubMed ID: 22342941
[TBL] [Abstract][Full Text] [Related]
29. Crucial Roles of LncRNAs-Mediated Autophagy in Breast Cancer.
Han X; Mo J; Yang Y; Wang Y; Lu H
Int J Med Sci; 2022; 19(6):1082-1092. PubMed ID: 35813295
[TBL] [Abstract][Full Text] [Related]
30. Autophagy-related microRNAs: Possible regulatory roles and therapeutic potential in and gastrointestinal cancers.
Pourhanifeh MH; Vosough M; Mahjoubin-Tehran M; Hashemipour M; Nejati M; Abbasi-Kolli M; Sahebkar A; Mirzaei H
Pharmacol Res; 2020 Nov; 161():105133. PubMed ID: 32822869
[TBL] [Abstract][Full Text] [Related]
31. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo.
Tao L; Zeng Y; Wang J; Liu Z; Shen B; Ge J; Liu Y; Guo Y; Qiu J
Mol Med Rep; 2015 Nov; 12(5):6533-46. PubMed ID: 26397152
[TBL] [Abstract][Full Text] [Related]
32. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
Kumar A; Rimando AM; Levenson AS
Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA in prostate cancer.
Khanmi K; Ignacimuthu S; Paulraj MG
Clin Chim Acta; 2015 Dec; 451(Pt B):154-60. PubMed ID: 26415820
[TBL] [Abstract][Full Text] [Related]
35. Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis.
Chen Z; Zhan Y; Chi J; Guo S; Zhong X; He A; Zheng J; Gong Y; Li X; Zhou L
EBioMedicine; 2018 Aug; 34():94-107. PubMed ID: 30037718
[TBL] [Abstract][Full Text] [Related]
36. Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers.
Seo E; Kang M
BMB Rep; 2023 Jan; 56(1):24-31. PubMed ID: 36476272
[TBL] [Abstract][Full Text] [Related]
37. RETRACTED: MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway.
Liao W; Zhang Y
Life Sci; 2020 Aug; 254():117672. PubMed ID: 32304760
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-mediated autophagic signaling networks and cancer chemoresistance.
Pan B; Yi J; Song H
Cancer Biother Radiopharm; 2013 Oct; 28(8):573-8. PubMed ID: 23841710
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
40. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance.
Shahverdi M; Hajiasgharzadeh K; Sorkhabi AD; Jafarlou M; Shojaee M; Jalili Tabrizi N; Alizadeh N; Santarpia M; Brunetti O; Safarpour H; Silvestris N; Baradaran B
Biomed Pharmacother; 2022 Apr; 148():112735. PubMed ID: 35193040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
